Figure 1From: Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis Pooled results for mean TCS during the peak ragweed pollen season in the Canadian subgroup and the entire population in two trials. Back to article page